From The Common Health Coalition, dated 8/25/2025:
Flu and RSV:
Flu and RSV recommendations and access are straightforward and remain similar to last year. The flu vaccination is recommended for everyone 6 months and older. RSV vaccinations are recommended for older adults, pregnant people, and infants.
COVID-19:
COVID-19 vaccines are safe, effective, and recommended.
FDA labels: On August 27, 2025, the FDA approved 2025-2026 COVID-19 vaccines with indications only for adults 65 and older and people 6 months to 64 years old with conditions that put them at high risk for severe illness. Read our full explainer.
- Pfizer (Comirnaty): Approved for use in individuals who are 65 years of age and older, or 5 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.
- Moderna (Spikevax): Approved for use in individuals who are 65 years of age and older, or 6 months through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.
- Novavax (Nuvaxovid): Approved for use in individuals who are 65 years of age and older, or 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.
Please speak with your health care provider if you have any questions.
